Olaparib
CAS 763113-22-0
In Stock
Olaparib
Cat. No. ANT-OPB-00CAS 763113-22-0In Stock
Technical Data
Cat. No.ANT-OPB-00
CAS763113-22-0
Mol. FormulaC24H23FN4O3
Mol. Weight434.47 g/mol
IUPAC4-[[3-[4-(cyclopropanecarbonyl)piperazine-1-carbonyl]-4-fluorophenyl]methyl]-2H-phthalazin-1-one
SMILESC1CC1C(=O)N2CCN(CC2)C(=O)C3=C(C=CC(=C3)CC4=NNC(=O)C5=CC=CC=C54)F
InChIInChI=1S/C24H23FN4O3/c25-20-8-5-15(14-21-17-3-1-2-4-18(17)22(30)27-26-21)13-19(20)24(32)29-11-9-28(10-12-29)23(31)16-6-7-16/h1-5,8,13,16H,6-7,9-12,14H2,(H,27,30)
InChI KeyFDLYAMZZIXQODN-UHFFFAOYSA-N
PurityNA
Description
Overview
Olaparib, sold under the brand name Lynparza, is a medication for the maintenance treatment of BRCA-mutated advanced ovarian cancer in adults
Anant Labs manufacture and furnish high quality Olaparib impurities for global markets. Our Olaparib EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.
Synonyms
4-[[3-[[4-(Cyclopropylcarbonyl)-1-piperazinyl]carbonyl]-4-fluorophenyl]methyl]-1(2H)-phthalazinoneOlaparib763113-22-0AZD2281LynparzaAZD-2281KU-0059436AZD 2281KU-59436WOH1JD9AR8
